The treatment of interstitial lung disease usually has consisted of corticosteroids with or
without either azathioprine or cyclophosphamide. These drugs mainly target the neutrophil …

Idiopathic pulmonary fibrosis (IPF) exhibits a complex and poorly understood pathogenesis.
Overt inflammation in the lungs of patients with established IPF is absent, and classic anti …

Cryptogenic fibrosing alveolitis (CFA), also known as idiopathic pulmonary fibrosis (IPF), is
the end stage of a heterogeneous group of disorders in which the deposition of excessive …

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing interstitial pneumonia characterized
by a poor response to therapy and a dismal prognosis. Historically, the fibrotic process in IPF …

The role of inflammation in idiopathic pulmonary fibrosis (IPF) is controversial. If
inflammation were critical to the disease process, lung pathology would demonstrate an …

Objective Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is of concern
because of its propensity for rapid deterioration and high mortality. Its aetiology and …

Background Idiopathic pulmonary fibrosis (IPF) pathogenesis involves multiple pathways,
and combined antifibrotic therapy is needed for future IPF therapy. Inhaled interferon-γ (IFN …

Fibrosis of the pulmonary interstitium is observed in a wide variety of disorders, including
infectious diseases, autoimmune disorders of connective tissue, and disorders where the …

Background: The only proven therapeutic option for idiopathic pulmonary fibrosis (IPF) is
lung transplantation. It is biologically plausible that interferon gamma-1b (G-IFN) may halt or …

Downloaded from by BhDMf5ePHKbH4TTImqenVA+ lpWIIBvonhQl60EtgtdlLYrLzSPu+
hQedJnbNaXBf on 11/21/2023 treated with interferon-α for hepatitis C. The patient had …